BillionToOne Interview Guide

BillionToOne is a pioneering molecular diagnostics company dedicated to developing advanced and precise diagnostic tests that are accessible to everyone. By utilizing innovative QCT molecular counting technology, the company enhances disease detection capabilities through cutting-edge cell-free DNA analysis. BillionToOne's flagship products, such as Unity Complete™, serve as a non-invasive prenatal screening tool, while the introduction of the Northstar liquid biopsy test marks its significant expansion into oncology, aiding in treatment selection and monitoring for patients. With over 500,000 patients already benefiting from its tests and a valuation exceeding $1 billion following substantial funding rounds, BillionToOne has established itself as a leader in the diagnostics field. The company is headquartered in Menlo Park, California, and prides itself on a vibrant and diverse company culture that fosters innovation and collaboration.